Development and validation of the gastric risk immuno-progression score (GRIPS) in advanced gastric and gastroesophageal junction adenocarcinoma treated with first-line chemotherapy plus nivolumab: Results from the ORACLE study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dario Spanu, Pina Ziranu, Andrea Pretta, Riccardo Cerantola, Francesca Salani, Silvia Ortolani, Emanuela Di Giacomo, Alessandra Pia D'Agata, Giada Grelli, Adelaide Mazzocca, Eleonora Perissinotto, Laura Pala, Francesco Mangogna, Jessica Lucchetti, Riccardo Giampieri, Lorenzo Fornaro, Alessandro Pastorino, Giuseppe Aprile, Floriana Nappo, Mario Scartozzi
Institutions: University of Cagliari, Azienda Ospedaliero-Universitaria Cagliari, Istituto Oncologico Veneto, Azienda Ospedaliera Universitaria Pisana, Ospedale San Bortolo, Azienda ULSS 8 Berica, Campus Bio Medico University Hospital, Marche Polytechnic University, Azienda Ospedaliero-Universitaria delle Marche, Humanitas Gavazzeni, Ospedale Policlinico San Martino, Azienda sanitaria universitaria Friuli Centrale
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816339